REAL-WORLD PROGRESSION PATTERNS IN FIRST AND SECOND LINES OF SYSTEMIC THERAPY FOR ENDOMETRIAL CANCER

被引:0
|
作者
Abreu, G. [1 ]
Queiroz, J. [1 ]
Nogueira da Silva, T. L. [1 ]
Soares, C. [1 ]
Menezes, P. [1 ]
Carrizo, M. [2 ]
Scibona, P. [3 ]
Simonovich, V. A. [3 ]
Riggi, M. C. [3 ]
Saadi, J. J. [3 ]
Cravero, F. [3 ]
Jotimliansky, L. [2 ]
机构
[1] GSK, Rio De Janeiro, Brazil
[2] GSK, Buenos Aires, DF, Argentina
[3] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
RWD156
引用
收藏
页码:S534 / S534
页数:1
相关论文
共 50 条
  • [1] Real-world treatment patterns in recurrent or advanced endometrial cancer patients on first-line systemic therapy in the United States
    Ogando, Yoscar M.
    Chen, Lei
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Miles, Nicola
    Green, Angela
    Makker, Vicky
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 233 - 234
  • [2] Exploring Breast Cancer Systemic Drug Therapy Patterns in Real-World Data
    O'Rourke, Julia
    Warnick, Jeff
    Doole, John
    De Keyser, Luc
    Drebert, Zuzanna
    Wan, Olivia
    Thompson, Courtney N.
    London, Jack W.
    Fairchild, Karen
    Palchuk, Matvey B.
    JCO CLINICAL CANCER INFORMATICS, 2023, 7 : e2300061
  • [3] Exploring Breast Cancer Systemic Drug Therapy Patterns in Real-World Data
    O'Rourke, Julia
    Warnick, Jeff
    Doole, John
    De Keyser, Luc
    Drebert, Zuzanna
    Wan, Olivia
    Thompson, Courtney N.
    London, Jack W.
    Fairchild, Karen
    Palchuk, Matvey B.
    JCO CLINICAL CANCER INFORMATICS, 2023, 7
  • [4] Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer
    Anton, Angelyn
    Pillai, Sruti
    Semira, Marie Christine
    Wong, Shirley
    Shapiro, Julia
    Weickhardt, Andrew
    Azad, Arun
    Kwan, Edmond M.
    Spain, Lavinia
    Gunjur, Ashray
    Torres, Javier
    Parente, Phillip
    Parnis, Francis
    Goh, Jeffrey
    Baenziger, Olivia
    Gibbs, Peter
    Tran, Ben
    BJUI COMPASS, 2022, 3 (03): : 205 - 213
  • [5] FIRST AND SECOND LINE TREATMENT CHOICES FOR ENDOMETRIAL CANCER: ECHOS-A REAL-WORLD STUDY
    Abreu, G.
    Queiroz, J.
    Nogueira da Silva, T. L.
    Soares, C.
    Menezes, P.
    Carrizo, M.
    Scibona, P.
    Simonovich, V. A.
    Riggi, M. C.
    Saadi, J. J.
    Cravero, F.
    Jotimliansky, L.
    VALUE IN HEALTH, 2023, 26 (12) : S527 - S527
  • [6] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE USE, AND COSTS BY LINE OF THERAPY AMONG ENDOMETRIAL CANCER PATIENTS NEWLY INITIATING SYSTEMIC THERAPIES
    Nwankwo, Chizoba
    Shah, Ruchitbhai
    Kebede, Nehemiah
    Shah, Anuj
    Corman, Shelby
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A34 - A35
  • [7] VALIDATION OF AN ALGORITHM TO IDENTIFY LINES OF THERAPY AMONG ADULT PATIENTS WITH ENDOMETRIAL AND OVARIAN CANCER IN A REAL-WORLD DATASET
    Luhar, S.
    Wallis, J.
    Picariello, F.
    Tunaru, F.
    Hatton, G.
    Carpenter, L.
    VALUE IN HEALTH, 2023, 26 (12) : S13 - S13
  • [8] Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States
    Liu, Jinan
    Emond, Bruno
    Maiese, Eric M.
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Ghelerter, Isabelle
    Wu, Caterina
    Hurteau, Jean A.
    Thaker, Premal H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1935 - 1945
  • [9] Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Ogando, Yoscar M.
    Verma, Rishi P.
    Grall, Veronique
    Marth, Christian
    FUTURE ONCOLOGY, 2024,
  • [10] REAL-WORLD TREATMENT PATTERNS IN RECURRENT OR ADVANCED ENDOMETRIAL CANCER PATIENTS WHO INITIATED SECOND-LINE SYSTEMIC THERAPY IN 5 EUROPEAN COUNTRIES: A RETROSPECTIVE CHART REVIEW STUDY
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Ogando, Yoscar M.
    Miles, Nicola
    Marth, Christian
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A188 - A188